Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV Infection.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Post-approval studies (Phase 4)Ended earlyNCT01467492
What this trial is testing

Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 121
Testing effectiveness (Phase 2)Study completedNCT00389298
What this trial is testing

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 36
Early research (Phase 1)Study completedNCT00866853
What this trial is testing

TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.

Who this might be right for
Hepatitis CViruses
Tibotec Pharmaceuticals, Ireland 16
Testing effectiveness (Phase 2)Study completedNCT01912495
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS)

Who this might be right for
Hepatitis CHuman Immunodeficiency Virus
Erasmus Medical Center 65
Not applicableApproved For MarketingNCT03123965
What this trial is testing

Expanded Access to Glecaprevir/ Pibrentasvir

Who this might be right for
Hepatitis C Virus Infection
AbbVie
Early research (Phase 1)Study completedNCT01525628
What this trial is testing

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 72
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Not applicableStudy completedNCT04971330
What this trial is testing

Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol

Who this might be right for
HCV
Beckman Coulter, Inc. 7,901
Not applicableUnknownNCT02102451
What this trial is testing

Control and Elimination Within Australia of Hepatitis C From People Living With HIV

Who this might be right for
Hepatitis CHIVHIV-HCV Coinfection
Kirby Institute 492
Post-approval studies (Phase 4)UnknownNCT02108301
What this trial is testing

Hepatitis C in Renal Transplant Recipients

Who this might be right for
Chronic Hepatitis C-virus InfectionRenal Transplantation
Prof. Dr. Alice Schmidt 30
Not applicableUnknownNCT03551002
What this trial is testing

Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego

Who this might be right for
Hepatitis CHepatitis C, ChronicHIV/AIDS
University of California, San Diego 450
Not applicableStudy completedNCT00894257
What this trial is testing

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

Who this might be right for
Hepatitis C VirusHIV InfectionsPregnancy
Centre Hospitalier Universitaire de Nice 142
Large-scale testing (Phase 3)WithdrawnNCT01447394
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01663922
What this trial is testing

Boceprevir and Ucalm (St John&Apos;s Wort)

Who this might be right for
Hepatitis C
St Stephens Aids Trust 17
Not applicableUnknownNCT03510637
What this trial is testing

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 7,500
Not applicableUnknownNCT03459768
What this trial is testing

Cohort Study on People Who Inject Drugs in Senegal

Who this might be right for
Drug AddictionHIV/AIDSHepatitis C, Chronic+6 more
French National Agency for Research on AIDS and Viral Hepatitis 208
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Testing effectiveness (Phase 2)Study completedNCT02249182
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 226
Post-approval studies (Phase 4)WithdrawnNCT03026023
What this trial is testing

Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant

Who this might be right for
Cardiac Transplant DisorderHepatitis C
Raymond T. Chung, MD
Next Page